Structure Therapeutics Inc. (GPCR)
NASDAQ: GPCR · Real-Time Price · USD
37.46
-0.61 (-1.60%)
Oct 24, 2024, 4:00 PM EDT - Market closed
Structure Therapeutics Market Cap
Structure Therapeutics has a market cap or net worth of $2.14 billion as of October 24, 2024. Its market cap has decreased by -9.23% in one year.
Market Cap
2.14B
Enterprise Value
1.26B
1-Year Change
-9.23%
Ranking
Category
Stock Price
$37.46
Market Cap Chart
Since the IPO on February 3, 2023, Structure Therapeutics's market cap has increased from $548.82M to $2.14B, an increase of 290.40%. That is a compound annual growth rate of 120.69%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 23, 2024 | 2.18B | 15.16% |
| Dec 29, 2023 | 1.89B | 244.50% |
| Feb 3, 2023 | 548.82M | - |
View and export this data all the way back to 2023.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ACADIA Pharmaceuticals | 2.41B |
| iRhythm Technologies | 2.36B |
| Addus HomeCare | 2.33B |
| Longboard Pharmaceuticals | 2.32B |
| Wave Life Sciences | 2.26B |
| Neumora Therapeutics | 2.23B |
| Vera Therapeutics | 2.23B |
| Keros Therapeutics | 2.23B |